Shares in Biotoscana, Knight Therapeutics up after deal announcement

Knight Therapeutics

21/10/2019 14:07

SAO PAULO, Oct 21 (Reuters) - Shares in Canada's Knight
Therapeutics  GUD.TO  were up 9% in Toronto after the
announcement of acquisition of Latin American pharmaceutical
company Biotoscana Investments  GBIO33.SA  earlier on Monday.
    Shares in Biotoscana were also up 4.9% at 10.26 reais in
mid-morning trading in Sao Paulo. In a securities filing, Knight
said will acquire a 51% interest in Biotoscana for 596 million
reais ($144 million), paying 10.26 reais per share. 

($1 = 4.1366 reais)

 (Reporting by Tatiana Bautzer; editing by David Evans)
 ((tatiana.bautzer@tr.com; Tel: +55-11-5644-7756; Mob:
+55-119-4210-4173; Reuters Messaging:
tatiana.bautzer.thomsonreuters.com@reuters.net))